29 maj: Solkystens luksuriøse oase – Marbella Club
31 maj: Skattereform: Ny kapitalpension er generationsrøveri til 150 mia...
29-05-2012 22:39:00

UPDATE: J&J Unit Gets FDA Warning Letter On K-Y Vaginal Moisturizer

Relateret indhold

(Updates with McNeil statement starting in the third paragraph.)

--FDA warns J&J unit on failure to properly investigate some consumer complaints

--Most of the letter details problems related to K-Y vaginal moisturizer

--FDA says a reporting problem related to O.B. Tampons has been adequately addressed

By Jennifer Corbett Dooren

Of DOW JONES NEWSWIRES

WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration said a Johnson & Johnson (JNJ) unit didn't properly investigate consumer complaints related to a vaginal moisturizer.

The agency, in a warning letter dated May 22, said the company received more than 200 complaints about K-Y liquibeads vaginal moisturizer, which is made by McNeil PPC Inc., from June 25, 2010, through Dec. 12, 2011. The agency said the complaints included reports of the product not dissolving or having an uncharacteristic consistency or texture. FDA said some of the complaints were closed without being investigated by the company. McNeil also didn't adequately investigate some complaints that contained an incorrect lot number, according to FDA.

In a statement, McNeil said it takes the issues raised by FDA seriously. "We will respond fully to their concerns and take whatever steps are needed to resolve these issues," the company said.

The warning letter was posted to the FDA's website on Tuesday. The letter stems from an inspection conducted by the FDA of a McNeil facility in Skillman, N.J. on Dec. 12, 2011 through Jan. 19, 2012.

The FDA also said the company was late in submitting a report about a person being diagnosed with toxic shock syndrome after using an O.B. Tampon, also made by McNeil. However, the FDA said the company had adequately responded to the agency's concerns about that report.

Johnson & Johnson's McNeil Consumer Healthcare unit has been working to address manufacturing problems that led to recalls of Tylenol and other over-the-counter products starting in 2009. Three of the company's manufacturing plants were placed under an FDA consent decree last year and one of the plants, in Fort Washington, Pa., is still shut down.

-By Jennifer Corbett Dooren, Dow Jones Newswires; 202-862-9294; jennifer.corbett@dowjones.com

(END) Dow Jones Newswires

May 29, 2012 16:39 ET (20:39 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo/Jyske: Hæver kursmål til 370 kr. fra 330 kr.

24-10-2017 09:10:28
Jyske Bank skruer op for sit kursmål for aktien i medicinalselskabet Novo Nordisk, der løftes til 370 kr. fra 330 kr.Anbefalingen fastholdes samtidig i positivt terræn på "køb".Det fremgår af data fra Bloomberg News.Novo Nordisk-aktien er tirsdag morgen startet uændret i 319,30 kr. Dermed indikerer Jyske Banks nye kursmål et fortsat kurspotentiale på 15,9 pct./ritzau/FINANSMikkel Brix Kvols +45 33..

Amerikansk oliefirma sætter dansk Nordsø-felt til salg

24-10-2017 08:34:30
Amerikanske Hess Corporation har sat sin ejerandel af det danske Syd Arne-felt i Nordsøen til salg. Det fortæller selskabet i en pressemeddelelse tirsdag.Hess er ved at fokusere sin forretning og har netop solgt aktiver i Norge til Aker BP for 2 mia. dollar (12,7 mia. kr.). Samtidig er salgsprocessen sat i gang i Danmark.Hess er operatør på og ejer 61,5 pct. af Syd Arne-feltet, der har produceret ..

Høreapparater: Sivantos-ledelse vil ikke sælge sminket lig

23-10-2017 15:32:25
I de seneste snart tre år har høreapparatproducenten Sivantos været under kapitalfonden EQT's vinger, efter at svenskerne overtog høreapparataktiviteterne fra kæmpekonglomeratet Siemens i november 2014.Dermed kan man måske så småt begynde at ænse et frasalg - eller en selvstændig børsnotering af selskabet - i horisonten, da kapitalfondernes formål typisk er at modne og effektivisere deres selskabe..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Amerikansk it-gigant bekræfter opkøb af softwareproducent - NY
2
Amerikansk oliefirma sætter dansk Nordsø-felt til salg
3
Mandagens aktier: Lundbeck og FLS sikrede akkurat plus til C20 Cap
4
DLH: Gyldent håndtryk til afgående topchef kvæler overskuddet
5
Novo/Jyske: Hæver kursmål til 370 kr. fra 330 kr.

Relaterede aktiekurser

Johnson & Johnson 143,62 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
24. oktober 2017 13:27:05
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171023.1 - EUROWEB2 - 2017-10-24 13:27:05 - 2017-10-24 13:27:05 - 1 - Website: OKAY